From Evan Harris <[email protected]>
Subject Another coronavirus lockdown would hurt these patients and providers
Date August 11, 2020 7:29 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
PRI's Focus on Health Care

View this email in your browser ([link removed])
Another coronavirus lockdown would hurt these patients and providers
Fox News | Sally C. Pipes
August 10, 2020

As they try to get the coronavirus‘ spread under control, states must resist the urge to impose blanket stay-at-home orders. Such draconian measures can cause people to postpone important medical care unrelated to COVID-19. The health costs of this foregone care are substantial – and could end up outweighing the benefits of another shutdown.
Read more. . . ([link removed])

Deaths Are An Incomplete Measure Of Covid-19’S Impact
American Council on Science and Health | Henry Miller, M.S., M.D. and Josh Bloom
August 10, 2020

Covid-19 is far more than a transient respiratory infection. Although it shares some pulmonary symptoms with influenza, for example severe pneumonia and a fever, once flu is gone, it’s gone and rarely leaves permanent damage. Not so with Covid-19. For example, “post-Covid pulmonary fibrosis” leaves permanent damage in the lungs, presumably resulting from blood clotting in the lungs. And it doesn’t stop there.
Read more. . . ([link removed])

[link removed]
Watch the Latest "Escape the Drug Pricing Maze Video"
Price Controls Won’t Solve Drug Affordability Problem

The Professor explains to Pete that some of the claims that he’s heard on TV about drug price controls are just spin. He shows Pete that whatever name you call them, drug price controls will reduce innovation and threaten people’s access to life-saving medicines.

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
Screenshot of the email generated on import

Message Analysis